Annual EBITDA:
-$420.08M-$35.22M(-9.15%)Summary
- As of today, AGIO annual EBITDA is -$420.08 million, with the most recent change of -$35.22 million (-9.15%) on December 31, 2024.
- During the last 3 years, AGIO annual EBITDA has fallen by -$50.91 million (-13.79%).
- AGIO annual EBITDA is now -2553.72% below its all-time high of -$15.83 million, reached on December 31, 2011.
Performance
AGIO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$125.80M-$20.45M(-19.41%)Summary
- As of today, AGIO quarterly EBITDA is -$125.80 million, with the most recent change of -$20.45 million (-19.41%) on June 30, 2025.
- Over the past year, AGIO quarterly EBITDA has dropped by -$21.57 million (-20.70%).
- AGIO quarterly EBITDA is now -3639.59% below its all-time high of $3.55 million, reached on September 30, 2014.
Performance
AGIO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$456.28M-$21.57M(-4.96%)Summary
- As of today, AGIO TTM EBITDA is -$456.28 million, with the most recent change of -$21.57 million (-4.96%) on June 30, 2025.
- Over the past year, AGIO TTM EBITDA has dropped by -$57.19 million (-14.33%).
- AGIO TTM EBITDA is now -9025.68% below its all-time high of -$5.00 million, reached on March 31, 2012.
Performance
AGIO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AGIO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -9.2% | -20.7% | -14.3% |
| 3Y3 Years | -13.8% | -31.9% | -18.3% |
| 5Y5 Years | -36.3% | -55.6% | -83.6% |
AGIO EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -13.8% | at low | -41.6% | at low | -24.3% | at low |
| 5Y | 5-Year | -36.3% | at low | -61.3% | at low | -83.6% | at low |
| All-Time | All-Time | -2553.7% | at low | -3639.6% | at low | -9025.7% | at low |
AGIO EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$125.80M(-19.4%) | -$456.28M(-5.0%) |
| Mar 2025 | - | -$105.35M(+14.8%) | -$434.71M(-3.5%) |
| Dec 2024 | -$420.08M(-9.2%) | -$123.67M(-21.9%) | -$420.08M(-4.7%) |
| Sep 2024 | - | -$101.47M(+2.6%) | -$401.29M(-0.5%) |
| Jun 2024 | - | -$104.22M(-14.9%) | -$399.10M(-3.2%) |
| Mar 2024 | - | -$90.72M(+13.5%) | -$386.76M(-0.5%) |
| Dec 2023 | -$384.86M(-1.2%) | -$104.87M(-5.6%) | -$384.86M(-2.0%) |
| Sep 2023 | - | -$99.27M(-8.0%) | -$377.35M(-2.8%) |
| Jun 2023 | - | -$91.89M(-3.5%) | -$367.18M(+0.9%) |
| Mar 2023 | - | -$88.82M(+8.8%) | -$370.64M(+2.6%) |
| Dec 2022 | -$380.48M(-3.1%) | -$97.36M(-9.3%) | -$380.48M(+1.4%) |
| Sep 2022 | - | -$89.11M(+6.5%) | -$385.75M(-0.0%) |
| Jun 2022 | - | -$95.35M(+3.4%) | -$385.58M(-1.7%) |
| Mar 2022 | - | -$98.67M(+3.9%) | -$379.11M(-2.7%) |
| Dec 2021 | -$369.18M(-13.2%) | -$102.63M(-15.4%) | -$369.18M(-5.7%) |
| Sep 2021 | - | -$88.94M(-0.1%) | -$349.30M(-3.2%) |
| Jun 2021 | - | -$88.87M(-0.2%) | -$338.33M(-2.4%) |
| Mar 2021 | - | -$88.74M(-7.2%) | -$330.31M(-1.3%) |
| Dec 2020 | -$326.13M(-5.8%) | -$82.74M(-6.1%) | -$326.13M(-31.2%) |
| Sep 2020 | - | -$77.97M(+3.6%) | -$248.56M(+9.5%) |
| Jun 2020 | - | -$80.85M(+4.4%) | -$274.68M(+8.9%) |
| Mar 2020 | - | -$84.56M(-1531.4%) | -$301.66M(+3.5%) |
| Dec 2019 | -$308.18M(+9.1%) | -$5.18M(+95.0%) | -$312.59M(+18.9%) |
| Sep 2019 | - | -$104.09M(+3.5%) | -$385.40M(-1.8%) |
| Jun 2019 | - | -$107.83M(-12.9%) | -$378.67M(-10.7%) |
| Mar 2019 | - | -$95.48M(-22.4%) | -$342.05M(-0.9%) |
| Dec 2018 | -$338.86M | -$77.99M(+19.9%) | -$338.86M(+3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$97.36M(-36.7%) | -$349.34M(-6.1%) |
| Jun 2018 | - | -$71.21M(+22.8%) | -$329.38M(+3.5%) |
| Mar 2018 | - | -$92.29M(-4.3%) | -$341.19M(-8.5%) |
| Dec 2017 | -$314.36M(-61.0%) | -$88.48M(-14.3%) | -$314.36M(-11.6%) |
| Sep 2017 | - | -$77.40M(+6.8%) | -$281.57M(-5.8%) |
| Jun 2017 | - | -$83.03M(-26.8%) | -$266.25M(-11.7%) |
| Mar 2017 | - | -$65.46M(-17.5%) | -$238.38M(-22.1%) |
| Dec 2016 | -$195.28M(-69.3%) | -$55.69M(+10.3%) | -$195.28M(-8.9%) |
| Sep 2016 | - | -$62.08M(-12.5%) | -$179.34M(-14.5%) |
| Jun 2016 | - | -$55.17M(-146.8%) | -$156.69M(-17.9%) |
| Mar 2016 | - | -$22.35M(+43.8%) | -$132.88M(-15.2%) |
| Dec 2015 | -$115.36M(-118.6%) | -$39.75M(-0.8%) | -$115.36M(-13.1%) |
| Sep 2015 | - | -$39.43M(-25.8%) | -$101.97M(-72.9%) |
| Jun 2015 | - | -$31.35M(-549.8%) | -$58.99M(-29.3%) |
| Mar 2015 | - | -$4.83M(+81.7%) | -$45.64M(+13.5%) |
| Dec 2014 | -$52.77M(-40.9%) | -$26.36M(-841.8%) | -$52.77M(-37.8%) |
| Sep 2014 | - | $3.55M(+119.7%) | -$38.30M(+27.1%) |
| Jun 2014 | - | -$18.00M(-50.6%) | -$52.55M(-23.1%) |
| Mar 2014 | - | -$11.95M(-0.4%) | -$42.70M(-14.0%) |
| Dec 2013 | -$37.44M(-71.6%) | -$11.90M(-11.3%) | -$37.44M(-18.1%) |
| Sep 2013 | - | -$10.69M(-31.2%) | -$31.71M(-50.9%) |
| Jun 2013 | - | -$8.15M(-21.7%) | -$21.02M(-12.3%) |
| Mar 2013 | - | -$6.70M(-8.5%) | -$18.72M(-10.0%) |
| Dec 2012 | -$21.82M(-37.8%) | -$6.17M(-5.5%) | -$17.02M(-56.9%) |
| Jun 2012 | - | -$5.85M(-17.0%) | -$10.85M(-117.0%) |
| Mar 2012 | - | -$5.00M | -$5.00M |
| Dec 2011 | -$15.83M | - | - |
FAQ
- What is Agios Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Agios Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Agios Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Agios Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of AGIO is -$420.08M
What is the all-time high annual EBITDA for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high annual EBITDA is -$15.83M
What is Agios Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, AGIO annual EBITDA has changed by -$35.22M (-9.15%)
What is Agios Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of AGIO is -$125.80M
What is the all-time high quarterly EBITDA for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high quarterly EBITDA is $3.55M
What is Agios Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, AGIO quarterly EBITDA has changed by -$21.57M (-20.70%)
What is Agios Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of AGIO is -$456.28M
What is the all-time high TTM EBITDA for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high TTM EBITDA is -$5.00M
What is Agios Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, AGIO TTM EBITDA has changed by -$57.19M (-14.33%)